Results 51 to 60 of about 113,759 (264)

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy

Case Reports in Obstetrics and Gynecology, 2016
Background. Diarrhea is a common problem in ovarian cancer patients undergoing chemotherapy and Clostridium difficile infection has been identified as a cause.
Valerie A. Allen, Kelly J. Manahan, John P. Geisler   +2 more
doaj   +1 more source

Clostridium difficile – still a problem among the XXI century in case of geriatic patient

Journal of Medical Science, 2017
Introduction. The disease caused by Clostridium difficile (CzcD - Clostridium difficile -associated disease) - was defined by the Centres for Disease Control and Prevention in Atlanta in 2007 in order to standardize monitoring conditions of diarrhea ...
Agnieszka Ulatowska, Katarzyna Plagens-Rotman, Małgorzata Piskorz-Szymendera, Elżbieta Włodarczyk, Natalia Smolarek, Izabela Miechowicz, Andrzej Jóźwiak, Grażyna Bączyk   +7 more
doaj   +1 more source

Clostridium Difficile and COVID-19: Novel Risk Factors for Acute Portal Vein Thrombosis

Case Reports in Vascular Medicine, 2021
The COVID-19 pandemic has created an unprecedented global health care crisis. COVID-19 patients are found to have increased thrombotic risk. Despite being on prophylactic anticoagulation, many develop serious arterial and venous thromboembolic events ...
Venkata Ram Pradeep Rokkam, Gurusaravanan Kutti Sridharan, Rathnamitreyee Vegunta, Radhakrishna Vegunta, Umesha Boregowda, Babu P. Mohan   +5 more
doaj   +1 more source

Microbiota Accessible Carbohydrates Suppress Clostridium difficile Infection in a Murine Model

Nature Microbiology, 2018
Clostridium difficile is an opportunistic diarrhoeal pathogen, and C. difficile infection (CDI) represents a major health care concern, causing an estimated 15,000 deaths per year in the United States alone1.
A. J. Hryckowian, William W. Van Treuren, S. Smits, N. M. Davis, Jackson O. Gardner, D. Bouley, J. Sonnenburg   +6 more
semanticscholar   +1 more source

Lauric acid is an inhibitor of Clostridium difficile growth in vitro and reduces inflammation in a mouse infection model [PDF]

, 2018
Indexación: Scopus.Clostridium difficile is a Gram-positive, spore-forming anaerobic human gastrointestinal pathogen. C. difficile infection (CDI) is a major health concern worldwide, with symptoms ranging from diarrhea to pseudomembranous colitis, toxic
Ababouch, Abt, Ananthakrishnan, Barbour, Bartolotta, Bergsson, Bhattacharjee, Buckley, Burke, Carpo, Chen, Clark, Croasdell, Crowther, Dapa, Dapa, Dayrit, de Roos, Deakin, Deng, Desai, Edwards, Ekanayaka, Eyres, Ferreyra, Fischer, Francis, Galbraith, German, Harnvoravongchai, Hinton, Huang, Hung, Hung, Immanuel, Johnson, Kabara, Katan, Kim, Kint, Kitahara, Kliewer, Liu, Louie, Lynch, Martin, Martin, May, McDonald, McEllistrem, Miller, Nakatsuji, Namkung, Nobmann, Pettit, Pizarro-Guajardo, Pruitt, Rodriguez-Palacios, Rouse, Ruhr, Ruzin, Shearer, Shilling, Smits, Sorg, Surawicz, Theinsathid, Thompson, Vardakas, Villafuerte Galvez, Wilcox, Yonezawa   +71 more
core   +1 more source

Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania

Romanian Journal of Laboratory Medicine, 2018
Introduction: The infection with Clostridium difficile has increased in incidence worldwide and it raises many problems with regard to therapy, resistance to treatment and especially recurrence.
Mihaela Laszlo, Pascu Oliviu, Leucuta Daniel-Corneliu, Andreica Vasile   +3 more
doaj   +1 more source

The Issue of Early Diagnosis of Intestinal Complications at Antibiotic Therapy in Children

Zdorovʹe Rebenka, 2015
The objective of the research was to improve the timely diagnosis of intestinal complications of antibiotic therapy, caused by Clostridium difficile infection in children.
O.A. Radutna, O.H. Ivanko, N.V. Kyzyma, O.S. Krut   +3 more
doaj   +1 more source

Clostridium difficile Infection: An Epidemiology Update

Clinics in Colon and Rectal Surgery, 2020
Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-associated infection and significant source of potentially preventable morbidity, recurrence, and death, particularly among hospitalized older adults.
Ana De Roo, S. Regenbogen
semanticscholar   +1 more source

Attenuated Bacteria‐Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies

Advanced Science, EarlyView.
This review comprehensively overviews attenuated bacteria‐based tumor therapy, highlighting key methodologies and recent progress. It examines strategies for enhancing safety, stabilizing efficacy, optimizing manufacturing, and navigating regulatory pathways.
Yucheng Liu, Junhong Yao, Jiaxin Deng, Minjie Zhou, Kaiyue Shen, Shishuo Sun, Xiaoge Gao, Qing Zhang, Haiheng Xu   +8 more
wiley   +1 more source

Effects of control interventions on Clostridium difficile infection in England: an observational study

Lancet. Infectious Diseases (Print), 2017
Summary Background The control of Clostridium difficile infections is an international clinical challenge. The incidence of C difficile in England declined by roughly 80% after 2006, following the implementation of national control policies; we tested ...
K. Dingle, X. Didelot, T. Quan, D. Eyre, N. Stoesser, Tanya Golubchik, R. Harding, Daniel J. Wilson, D. Griffiths, A. Vaughan, John M Finney, D. Wyllie, S. Oakley, W. Fawley, J. Freeman, K. Morris, Jessica S. H. Martin, P. Howard, S. Gorbach, E. Goldstein, D. Citron, S. Hopkins, R. Hope, Alan P. Johnson, M. Wilcox, T. Peto, A. Walker, D. Crook, Carlos Charles Vasiliki Adam Jim Del Ojo Elias Crichton Kostiou Giess Davies, Carlos del Ojo Elias, C. Crichton, V. Kostiou, A. Giess, J. Davies   +33 more
semanticscholar   +1 more source